Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis
Condition: Knee Osteoarthritis · Sponsor: MiMedx Group, Inc.
About this study
The purpose of this study is to determine the safety and efficacy of the 40 mg and 100 mg doses of allogeneic micronized dehydrated human amnion/chorion membrane (micronized DHACM) injectable compared to 0.9% sodium chloride injection, placebo control for the treatment of knee osteoarthritis
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (14)
| Horizon Clinical Research | La Mesa, California, United States | — |
| AppleMed Research Group, LLC | Miami, Florida, United States | — |
| Health and Life Research Institute, LLC | Miami, Florida, United States | — |
| Vista Health Research, LLC | Miami, Florida, United States | — |
| Premier Medical Associates | The Villages, Florida, United States | — |
| Elite Clinical Trials, LLLP | Blackfoot, Idaho, United States | — |
| Healthcare Research Network | Hazelwood, Missouri, United States | — |
| Rochester Clinical Research, Inc. | Rochester, New York, United States | — |
| University Orthopedics Center - Altoona | Altoona, Pennsylvania, United States | — |
| University Orthopedics Center - State College | State College, Pennsylvania, United States | — |
| Clinical Trials of South Carolina | Charleston, South Carolina, United States | — |
| Piedmont Research Partners, LLC | Fort Mill, South Carolina, United States | — |
+ 2 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05796765